COPD Trial, Recruiting (NCT07635446)

COPD Trial, Recruiting NCT07635446 Sponsor: Riphah International University Condition: COPD

Printed from Voxsanity (voxsanity.com.au) — NCT07635446 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Copd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People of any gender (male or female) may be considered.
People between the ages of 40 and 60 years old.
People who have been diagnosed with COPD (a long-term lung condition that makes it hard to breathe).
People who are willing to take part in the trial.

Who may not be able to join:

People who have had a sudden worsening of their COPD symptoms (called a flare-up or exacerbation) within the past 4 weeks.
People who have heart conditions, such as a recent heart attack or heart failure.
People who have a disorder affecting their muscles or nerves (a condition where the nerves and muscles do not work properly together).
People who have been recently diagnosed with or treated for a lung disease other than COPD (confirm with trial site).
People whose blood circulation or blood pressure is unstable or not working as it should.
People who are experiencing respiratory failure, meaning their lungs are not able to maintain normal breathing on their own.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Arjumand Bano, MS, Riphah International University

Phone: 333826752

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07635446

Sponsor: Riphah International University

Phase: Not Applicable

Status: Recruiting

Condition: COPD

Trial contact: 333826752

More information: https://clinicaltrials.gov/study/NCT07635446

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People of any gender (male or female) may be considered.
People between the ages of 40 and 60 years old.
People who have been diagnosed with COPD (a long-term lung condition that makes it hard to breathe).
People who are willing to take part in the trial.

Who may not be able to join:

People who have had a sudden worsening of their COPD symptoms (called a flare-up or exacerbation) within the past 4 weeks.
People who have heart conditions, such as a recent heart attack or heart failure.
People who have a disorder affecting their muscles or nerves (a condition where the nerves and muscles do not work properly together).
People who have been recently diagnosed with or treated for a lung disease other than COPD (confirm with trial site).
People whose blood circulation or blood pressure is unstable or not working as it should.
People who are experiencing respiratory failure, meaning their lungs are not able to maintain normal breathing on their own.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Riphah International University

Registry

ClinicalTrials.gov

Start date

1 June 2026

Est. completion

1 August 2026

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Change in Anxiety Severity Assessed by the Generalized Anxiety Disorder-7; Pitts burg Sleep Quality index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov